Redox Biology (Nov 2023)

Fullerol rescues the light-induced retinal damage by modulating Müller glia cell fate

  • Zhe Cha,
  • Zhiyuan Yin,
  • Luodan A,
  • Lingling Ge,
  • Junling Yang,
  • Xiaona Huang,
  • Hui Gao,
  • Xia Chen,
  • Zhou Feng,
  • Lingyue Mo,
  • Juncai He,
  • Shuang Zhu,
  • Maoru Zhao,
  • Zui Tao,
  • Zhanjun Gu,
  • Haiwei Xu

Journal volume & issue
Vol. 67
p. 102911

Abstract

Read online

Excessive light exposure can damage photoreceptors and lead to blindness. Oxidative stress serves a key role in photo-induced retinal damage. Free radical scavengers have been proven to protect against photo-damaged retinal degeneration. Fullerol, a potent antioxidant, has the potential to protect against ultraviolet-B (UVB)-induced cornea injury by activating the endogenous stem cells. However, its effects on cell fate determination of Müller glia (MG) between gliosis and de-differentiation remain unclear. Therefore, we established a MG lineage-tracing mouse model of light-induced retinal damage to examine the therapeutic effects of fullerol. Fullerol exhibited superior protection against light-induced retinal injury compared to glutathione (GSH) and reduced oxidative stress levels, inhibited gliosis by suppressing the TGF-β pathway, and enhanced the de-differentiation of MG cells. RNA sequencing revealed that transcription candidate pathways, including Nrf2 and Wnt10a pathways, were involved in fullerol-induced neuroprotection. Fullerol-mediated transcriptional changes were validated by qPCR, Western blotting, and immunostaining using mouse retinas and human-derived Müller cell lines MIO-M1 cells, confirming that fullerol possibly modulated the Nrf2, Wnt10a, and TGF-β pathways in MG, which suppressed gliosis and promoted the de-differentiation of MG in light-induced retinal degeneration, indicating its potential in treating retinal diseases.

Keywords